Abstract:To investigate the therapeutic effect of nano-sized liposomal adriamycin (NLADR) administered by various routes on rabbits bearing advanced breast tumors.NLADR with a mean diameter of 120 nm was prepared by pH gradient-driven drug encapsulation method. VX(2) tumor mass suspension was injected into the breast tissues of 50 female New Zealand White rabbits. Six weeks after the inoculation 38 surviving tumor-bearing rabbits were randomly divided into 5 groups: group A (control group), receiving a sham treatment; group B, receiving subcutaneous injection of NLADR with a dose of 1 mg/kg into the areas adjacent to the implanted tumor; group C, receiving intravenous injection of NLADR with a dose of 1 mg/kg; group D, receiving NLADR with a dose of 1 mg/kg administered by subcutaneous injection combined with intravenous injection with half of the whole dose for both routes; and group E, receiving intravenous injection of free adriamycin (FADR). The treatment was repeated every 48 hours. The rabbits were killed 48 hours after the third treatment. The breast tumors, axillary lymph nodes, and all of the metastatic tumors anatomically detected in distant organs were collected. The sizes of tumors and axillary nodes before and after treatment were measured. Necrosis of tumor tissue was assessed pathologically. The mRNA expression of proliferating cell nuclear antigen (PCNA) was determined using RT-PCR. Apoptosis was identified and quantified as apoptosis index (AI) using TUNEL method.The average growth rate of tumor was the highest in group A (1.58) and the lowest in group C (1.33). The average growth rate of axillary lymph nodes was the highest in group A (3.70), significantly higher than in any other groups (all P = 0.00); and was the lowest in group B, significantly lower than groups A, C, and E (all P < 0.01), however without a significant difference between groups B and D (P = 0.148). The PCNA mRNA expression level of the implanted tumor in groups C was the lowest, significant lowest then those in group A and B (both P < 0.01). The sequence of PCNA mRNA in the axillary lymph nodes was group B < group D < group C < group E < group A with significant differences between group B and groups A, C, and E. The sequence of PCNA mRNA in the mediastinal lymph nodes was group B < Group E < group D < group C < group A. The PCNA mRNA expression level was the lowest in group D, significantly lower than that in group A (P = 0.011). Necrosis of implanted tumor, metastatic foci in lung and liver, and lymph nodes was obvious in groups C, D, and E. Necrosis of implanted tumor and metastatic foci in lung and liver was significantly obvious in group C than in group D (P = 0.000 and P = 0.022). Necrosis of the implanted tumor was significantly more obvious in group C than in group F (P = 0.033). Necrosis of axillary lymph nodes was significantly more obvious in group than in groups C and E (P = 0.000 and P = 0.000). The values of AI of the implanted tumor in groups C and D were 16.74% and 18.04%, both significantly higher than those in group E (P = 0.02 and P = 0.04), and those of group E were significantly higher than those in groups A and B (both P < 0.01). The AI value of the axillary lymph nodes was 21.73%, significantly than those in groups A, C, and E (all P < 0.01). The average AI values of the metastatic foci were 16.52%, 15.77%, and 14.50%, all significantly higher than that in group B (all P < 0.01), and that of group B was significantly higher than that in group A (P = 0.039).NLADR, especially intravenous administration combined with subcutaneous administration, is effective in treatment of advanced breast carcinoma with lymphatic and distant metastases.

Local Administration of Liposomal Adriamycin Inhibited Proliferation of Metastatic Cells in Axillary Lymph Nodes in Rabbit Breast Cancer Model

Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model.

Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes]

Local administration of activated carbon-adsorbed mitomycin C in treatment of breast cancer model with metastasized axillary lymph nodes

[Influence of As2O3-lipiodol Emulsion Via Transarterial Embolization on a VX2 Liver Tumor Model in Rabbits].

The Effect of Self-Assembly Multiplayer Microcapsules Loaded with Doxorubicin on the Cellular Metabolism and Apoptosis of the Rabbit VX2 Hepatic Tumor Model

Experimental Study on Metastasis and Correlation of Metastasis with Angiogenesis of Hepatic Tumor in Rabbits after Transcatheter Arterial Chemoembolization Using As2O3 and Lipiodol

Effects of transcatheter arterial chemoembolization on growth and metastasis of rabbit VX2 hepatic tumor

Liver Targeting and the Delayed Drug Release of the Nanoparticles of Adriamycin Polybutylcyanoacrylate in Mice

Study on Adverse Effects of Poly(N-isopropylacrylamide) Adriamycin Magnetic Nanoparticles Via Transarterial Embolization on Liver VX2 Tumor in Rabbits

[Regional lymph nodes targetting with enrichment of polyphase liposome]

Effect of docetaxel-loaded lipid microbubbles combined with ultrasound targeted microbubbles destruction on microvessel of rabbit VX2 liver tumor models

[Antitumor Effect of Recombinant Xenopus Laevis Vascular Endothelial Growth Factor (VEGF) As a Vaccine Combined with Adriamycin on EL4 Lymphoma in Mice].

Lymphatic Targeting Chemotherapy for Refractory Lymph Nodes in Patients with Breast Cancer after Neoadjuvant Chemotherapy: Preliminary Experience.

[Experimental Studies on Adriamycin Alginate-Chitosan Microcapsules in the Treatment of Rabbit VX2 Carcinoma in the Extremity].

The Efficacy and Hyperthermic Release of Doxorubicin from Liposomal Doxorubicin Hydrochloride in Rabbit VX2 Tumours

Inhibiting effect of Duffy antigen receptor for chemokines on growth of lung adenocarcinoma A549 xenografts in nude mice and its possible mechanism

Intra-arterial delivery of doxorubicin-loaded hollow gold nanospheres-photothermal ablation and chemoembolisation therapy in a rabbit VX2 liver cancer model

Docetaxel administered through a novel lymphatic drug delivery system (LDDS) improved treatment outcomes for lymph node metastasis

LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics.

Preoperative Lymphangial Chemotherapy on Breast Carcinoma